On 16 January 2015 la Fédération Française de Savate Boxe Française et Disciplines Associées (FFSBFDA), the French Federation for Savate, French Boxing and Associated Disciplines, decided to impose a 3 month period of ineligibility on the Respondent M43 after his sample tested positive in December 2014 for the prohibited substance tuaminoheptane.
Hereafter in April 2015 the French Anti-Doping Agency (AFLD) opened disciplinary proceedings against Respondent M43. The Respondent admitted the violation without intention to enhance his performance. He stated that he used prescribed medication Rhinofluimucil, containing tuaminoheptane, as treatment for his rhinorrhea nose condition.
He mentioned the use of the medication on the Doping Control Form and admitted he did not research or consult his doctor about prohibited substances before using the medication.
Considering the Respondent’s statement the AFLD concludes that he acted negligence because he failed to research the ingredients before using the medication.
Therefore the AFLD decides on 24 September 2015 to annul the FFSBFDA decision of 16 January 2015 and to impose a 6 month period of inegligibility on the Respondent.
